Andrew Hirsch Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Andrew Hirsch.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Andrew Hirsch. Andrew Hirsch is COO and CFO in BIND Therapeutics, Inc ($BIND) and PRESIDENT & CEO in BIND Therapeutics, Inc ($BIND) and Chief Financial Officer in AGIOS PHARMACEUTICALS INC ($AGIO) and Director in Editas Medicine, Inc. ($EDIT) and See Remarks in C4 Therapeutics, Inc. ($CCCC).
Latest Insider Trading Transactions of Andrew Hirsch
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AGIO, CCCC, BIND, EDIT
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 05 2020 | CCCC | C4 Therapeutics, I ... | Hirsch Andrew | See Remarks | Option Exercise | A | 19.00 | 1,691,672 | 32,141,768 | 1,691,672 | |
Jun 12 2020 | EDIT | Editas Medicine, I ... | Hirsch Andrew | Director | Option Exercise | A | 27.49 | 11,538 | 317,180 | 11,538 | |
Apr 24 2020 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Option Exercise | M | 0.00 | 5,893 | 0 | 11,785 | |
Apr 24 2020 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Payment of Exercise | F | 45.91 | 1,927 | 88,469 | 24,272 | 26.2 K to 24.3 K (-7.36 %) |
Apr 24 2020 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Buy | M | 0.00 | 5,893 | 0 | 26,199 | 20.3 K to 26.2 K (+29.02 %) |
Apr 15 2020 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Option Exercise | M | 0.00 | 5,387 | 0 | 10,775 | |
Apr 15 2020 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Payment of Exercise | F | 40.64 | 1,599 | 64,983 | 20,306 | 21.9 K to 20.3 K (-7.30 %) |
Apr 15 2020 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Buy | M | 0.00 | 5,387 | 0 | 21,905 | 16.5 K to 21.9 K (+32.61 %) |
Feb 25 2020 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Option Exercise | M | 0.00 | 3,333 | 0 | 6,667 | |
Feb 25 2020 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Payment of Exercise | F | 48.66 | 1,056 | 51,385 | 16,518 | 17.6 K to 16.5 K (-6.01 %) |
Feb 25 2020 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Buy | M | 0.00 | 3,333 | 0 | 17,574 | 14.2 K to 17.6 K (+23.40 %) |
Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Option Exercise | M | 0.00 | 2,750 | 0 | 2,750 | |
Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Option Exercise | A | 51.51 | 45,000 | 2,317,950 | 45,000 | |
Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Option Exercise | A | 0.00 | 12,000 | 0 | 12,000 | |
Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Payment of Exercise | F | 52.01 | 886 | 46,081 | 14,241 | 15.1 K to 14.2 K (-5.86 %) |
Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Buy | M | 0.00 | 2,750 | 0 | 15,127 | 12.4 K to 15.1 K (+22.22 %) |
Jun 14 2019 | EDIT | Editas Medicine, I ... | Hirsch Andrew | Director | Option Exercise | A | 21.74 | 11,538 | 250,836 | 11,538 | |
Apr 24 2019 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Option Exercise | A | 0.00 | 17,678 | 0 | 17,678 | |
Feb 26 2019 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
Feb 26 2019 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Option Exercise | A | 58.86 | 40,000 | 2,354,400 | 40,000 | |
Feb 20 2019 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Option Exercise | M | 0.00 | 2,750 | 0 | 5,500 | |
Feb 20 2019 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Payment of Exercise | F | 58.03 | 821 | 47,643 | 12,374 | 13.2 K to 12.4 K (-6.22 %) |
Feb 20 2019 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Buy | M | 0.00 | 2,750 | 0 | 13,195 | 10.4 K to 13.2 K (+26.33 %) |
Jan 23 2019 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Option Exercise | M | 0.00 | 15,000 | 0 | 0 | |
Jan 23 2019 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Payment of Exercise | F | 52.82 | 4,555 | 240,595 | 10,445 | 15 K to 10.4 K (-30.37 %) |
Jan 23 2019 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Buy | M | 0.00 | 15,000 | 0 | 15,000 | 0 to 15 K |
Jul 24 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
Jun 19 2018 | EDIT | Editas Medicine, I ... | Hirsch Andrew | Director | Option Exercise | A | 37.50 | 11,538 | 432,675 | 11,538 | |
Feb 20 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Option Exercise | A | 0.00 | 8,250 | 0 | 8,250 | |
Feb 20 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Option Exercise | A | 77.70 | 33,000 | 2,564,100 | 33,000 | |
May 31 2017 | EDIT | Editas Medicine, I ... | Hirsch Andrew | Director | Option Exercise | A | 13.75 | 23,076 | 317,295 | 23,076 | |
Feb 23 2017 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Option Exercise | A | 50.40 | 47,600 | 2,399,040 | 47,600 | |
Sep 21 2016 | AGIO | AGIOS PHARMACEUTIC ... | Hirsch Andrew | Chief Financial Off ... | Option Exercise | A | 49.83 | 125,000 | 6,228,750 | 125,000 | |
Jun 23 2015 | BIND | BIND Therapeutics, ... | Hirsch Andrew | PRESIDENT & CEO | Option Exercise | A | 5.86 | 20,000 | 117,200 | 20,000 | |
Mar 10 2015 | BIND | BIND Therapeutics, ... | Hirsch Andrew | PRESIDENT & CEO | Option Exercise | A | 5.96 | 140,000 | 834,400 | 140,000 | |
Mar 13 2014 | BIND | BIND Therapeutics, ... | Hirsch Andrew | COO and CFO | Option Exercise | A | 12.81 | 45,000 | 576,450 | 45,000 |
Page: 1